CLINICAL TRIALS PROFILE FOR ELDECALCITOL
✉ Email this page to a colleague
Clinical Trials for Eldecalcitol
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT01974167 ↗ | Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol | Unknown status | e-GLORIA trial Protocol Review Committee | N/A | The purpose of this study is to evaluate the efficacy and safety of eldecalcitol monotherapy compared with alfacalcidol monotherapy in patients with glucocorticoid-induced osteoporosis, using a randomized, open-label, parallel-group, comparative design. |
| NCT02306187 ↗ | The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis | Recruiting | Shinshu University | Phase 1 | In the patients with osteoporosis, bisphosphonates (BPs) are a golden standard treatment. However, the bone turnover markers or the bone mineral density (BMD) are not improved in some osteoporotic patients even though they have taken BPs and alfacalcidol more than several years. In those case, the investigators better off prescribing BPs and Eldecalcitol, instead of BPs and Alfacalcitol. |
| NCT03755193 ↗ | Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients | Recruiting | Shinshu University | Phase 2 | The aim of this study is to examine the efficacy and adverse events in the following 3 groups in Japanese osteoporosis patients after 2-year-denosumab therapy: SERM and eldecalcitol treatment for 24 months Bisphosphonates and eldecalcitol treatment for 24 months Eldecalcitol treatment for 24 months |
| NCT05406050 ↗ | Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects | Completed | Wenzhou Haihe Pharmaceutical Co., Ltd. | Phase 1 | A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy Chinese subjects under fasting conditions. |
| NCT05406050 ↗ | Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects | Completed | The Affiliated Hospital of Qingdao University | Phase 1 | A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy Chinese subjects under fasting conditions. |
| NCT05884372 ↗ | Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis. | Not yet recruiting | Chugai Pharma China Co., Ltd. | Phase 4 | Primary objective: To compare the bone mineral density (BMD) change under the treatment of denosumab with eldecalcitol or native vitamin D in postmenopausal women with osteoporosis on bone mineral density. Secondary objective: To compare the efficacy of denosumab with eldecalcitol or native vitamin D treatment in postmenopausal women with osteoporosis on bone turnover markers, serum PTH, serum calcium, serum phosphorus, muscle mass, muscle strength, body balance ability, and quality of life. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Eldecalcitol
Condition Name
Clinical Trial Locations for Eldecalcitol
Clinical Trial Progress for Eldecalcitol
Clinical Trial Phase
Clinical Trial Sponsors for Eldecalcitol
Sponsor Name
